The Hamner Institutes for Health Sciences to Present at 2012 Society of Toxicology Annual Meeting
Expert Scientists for Leading Health Sciences Institute to Present 40-Plus Topics at SOT 51s Annual Meeting & ToxExpo in San Francisco
Research Triangle Park, NC, March 11, 2012 --(PR.com)-- The Hamner Institutes for Health Sciences (http://www.thehamner.org) has announced that its scientists will be presenting more than 40 talks and posters and leading workshops on topics covering a variety of current trends and issues in the field of toxicology at the Society of Toxicology’s 51st Annual Meeting & ToxExpoTM running Sunday, March 11 through Thursday, March 15 at the Moscone Convention Center, located at 747 Howard St. in San Francisco. More information on the meeting can be found at http://www.toxicology.org/ai/meet/am2012/am.asp.
Hamner scientists will take part in several joint presentations and workshops with scientists from the U.S. Environmental Protection Agency, Dow Chemical Company, Unilever, Agilent Technologies, UNC-Chapel Hill and other preeminent organizations.
Triangle Research Labs, LLC, a joint venture between The Hamner Institutes and PBM Capital Group, a Charlottesville, Va.-based investment group with significant interests in biotech and life sciences, will be an exhibitor in ToxExpoTM (Booth #303).
Select Presentations and Workshops by The Hamner:
For a detailed list of Hamner scientist presentations, posters and workshops, visit: http://www.thehamner.org/news-events/entry/society-of-toxicology-annual-meeting-2012
Sunday, March 11
1:15 p.m.: The Use of Physiologically-Based Pharmacokinetic Modeling to Inform Early Life Sensitivity to Chemical Toxicity
Monday, March 12
9:15 a.m.: High-Throughput In Vitro Toxicity Testing: A Mid-Course Assessment of Predictive Accuracy for In Vivo Endpoints and Use in Decision-Making
2 p.m.: Concepts Critical to the Next Generation of Human Health and Ecological Risk Assessment
2 p.m.: Exposure Assessment: Biological and Probabilistic Approaches to Monitoring, Modeling and Predictions
Tuesday, March 13
9 a.m.: Cross-Species Analysis of Toxicogenomics Data: Approaches for Assessing Differences in Sensitivity and Conservation of Mode of Action
9 a.m.: Emerging Methodologies for Genotoxicity Assessment
1:30 p.m.: Risk Assessment Approaches: Data-Derived Extrapolations, QSAR, In Silico Strategies and Surrogates
Wednesday, March 14
Noon: Scientific, Regulatory, and Public Perspectives on the Credibility and Use of Alternative Toxicological Test Methods in a Legislative Framework
1:30 p.m.: Computational Toxicology: Predicting Hepatotoxicity
1:30 p.m.: Risk Analysis: New Derivations and Updated Debates
New Media Content:
- The Hamner’s Twitter page
http://www.twitter.com/thehamner
About The Hamner Institutes for Health Sciences:
The Hamner Institutes for Health Sciences is a nonprofit research organization located in the heart of Research Triangle Park (RTP), N.C. The two flagship institutes at The Hamner, the Institute for Chemical Safety Sciences and the Hamner-UNC Institute for Drug Safety Sciences, build upon 35 years of preeminent research in toxicology and human health research to develop and validate new cutting-edge tools for safety assessment. Novel technologies currently being developed include in silico models for predictive toxicology, in vitro models that utilize human cells or cell lines to evaluate perturbations of cellular responses, and in vivo models to elucidate genes that play a role in susceptibility to drug-induced toxicities. The Hamner continues to grow its open, multidisciplinary campus through global partnerships with academia, industry, and government, and remains dedicated to positively impacting human health. For more information, please visit http://www.thehamner.org.
Erin Smith
MMI Public Relations
(919) 233-6600
erin@mmipublicrelations.com
http://twitter.com/MMIPR
http://www.mmipublicrelations.com
###
Hamner scientists will take part in several joint presentations and workshops with scientists from the U.S. Environmental Protection Agency, Dow Chemical Company, Unilever, Agilent Technologies, UNC-Chapel Hill and other preeminent organizations.
Triangle Research Labs, LLC, a joint venture between The Hamner Institutes and PBM Capital Group, a Charlottesville, Va.-based investment group with significant interests in biotech and life sciences, will be an exhibitor in ToxExpoTM (Booth #303).
Select Presentations and Workshops by The Hamner:
For a detailed list of Hamner scientist presentations, posters and workshops, visit: http://www.thehamner.org/news-events/entry/society-of-toxicology-annual-meeting-2012
Sunday, March 11
1:15 p.m.: The Use of Physiologically-Based Pharmacokinetic Modeling to Inform Early Life Sensitivity to Chemical Toxicity
Monday, March 12
9:15 a.m.: High-Throughput In Vitro Toxicity Testing: A Mid-Course Assessment of Predictive Accuracy for In Vivo Endpoints and Use in Decision-Making
2 p.m.: Concepts Critical to the Next Generation of Human Health and Ecological Risk Assessment
2 p.m.: Exposure Assessment: Biological and Probabilistic Approaches to Monitoring, Modeling and Predictions
Tuesday, March 13
9 a.m.: Cross-Species Analysis of Toxicogenomics Data: Approaches for Assessing Differences in Sensitivity and Conservation of Mode of Action
9 a.m.: Emerging Methodologies for Genotoxicity Assessment
1:30 p.m.: Risk Assessment Approaches: Data-Derived Extrapolations, QSAR, In Silico Strategies and Surrogates
Wednesday, March 14
Noon: Scientific, Regulatory, and Public Perspectives on the Credibility and Use of Alternative Toxicological Test Methods in a Legislative Framework
1:30 p.m.: Computational Toxicology: Predicting Hepatotoxicity
1:30 p.m.: Risk Analysis: New Derivations and Updated Debates
New Media Content:
- The Hamner’s Twitter page
http://www.twitter.com/thehamner
About The Hamner Institutes for Health Sciences:
The Hamner Institutes for Health Sciences is a nonprofit research organization located in the heart of Research Triangle Park (RTP), N.C. The two flagship institutes at The Hamner, the Institute for Chemical Safety Sciences and the Hamner-UNC Institute for Drug Safety Sciences, build upon 35 years of preeminent research in toxicology and human health research to develop and validate new cutting-edge tools for safety assessment. Novel technologies currently being developed include in silico models for predictive toxicology, in vitro models that utilize human cells or cell lines to evaluate perturbations of cellular responses, and in vivo models to elucidate genes that play a role in susceptibility to drug-induced toxicities. The Hamner continues to grow its open, multidisciplinary campus through global partnerships with academia, industry, and government, and remains dedicated to positively impacting human health. For more information, please visit http://www.thehamner.org.
Erin Smith
MMI Public Relations
(919) 233-6600
erin@mmipublicrelations.com
http://twitter.com/MMIPR
http://www.mmipublicrelations.com
###
Contact
The Hamner Institutes for Health Sciences
Patty Briguglio
919-233-6600
Patty Briguglio
919-233-6600
Contact
Categories